In vitro evaluation of an injectable chitosan gel for sustained local delivery of BMP-2 for osteoblastic differentiation

Journal of Biomedical Materials Research - Part B Applied Biomaterials

Volumn 99 B, Issue 2, 2011, Pages 380-390

  Kim, Sungwoo ^a   Tsao, Helen ^a   Kang, Yunqing ^a   Young, Daniel A ^a   Sen, Milan ^a   Wenke, Joseph C ^b   Yang, Yunzhi ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b US ARMY INSTITUTE OF SURGICAL RESEARCH   (United States)

Author keywords

glycerophosphate ( GP); biocompatibility; BMP 2; chitosan; HEPM; injectable gel; osteoblastic differentiation; release profile; W 20 17

Indexed keywords

BMP-2; GLYCEROPHOSPHATE; HEPM; INJECTABLE GEL; OSTEOBLASTIC DIFFERENTIATION; RELEASE PROFILES; W-20-17;

BIOCOMPATIBILITY; DRUG PRODUCTS; GELS; MAMMALS; PHOSPHOLIPIDS;

CHITOSAN;

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; CHITOSAN; OSTEOCALCIN;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL TYPE; CELL VIABILITY; CONTROLLED STUDY; DRUG RELEASE; GEL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; PROTEIN SYNTHESIS;

ALKALINE PHOSPHATASE; ANIMALS; ANTHRAQUINONES; BIOCOMPATIBLE MATERIALS; BONE MARROW CELLS; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CHITOSAN; DRUG DELIVERY SYSTEMS; GELS; HUMANS; MICE; OSTEOBLASTS; STROMAL CELLS; TIME FACTORS;

EID: 80054103147     PISSN: 15524973     EISSN: 15524981     Source Type: Journal    
DOI: 10.1002/jbm.b.31909     Document Type: Article

References (49)

1. Bessa PC, Casal M, Reis RL,. Bone morphogenetic proteins in tissue engineering: The road from the laboratory to the clinic, part I (basic concepts). J Tissue Eng Regen Med 2008; 2: 1-13.
2. He TC,. Distinct osteogenic activity of BMPs and their orthopaedic applications. J Musculoskelet Neuronal Interact 2005; 5: 363-366.
3. Hogan BL,. Bone morphogenetic proteins: Multifunctional regulators of vertebrate development. Genes Dev 1996; 10: 1580-1594. (Pubitemid 26268864)
4. Biase PD, Capanna R, Clinical applications of BMPs. Injury, Int J Care Injured 2005; 36S: S43-S46.
5. McKay WF, Peckham SM, Badura JM,. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE® bone graft). Int Orthop 2007; 31: 729-734. (Pubitemid 350160311)
6. Kato M, Toyoda H, Namikawa T, Hoshino M, Terai H, Takaoka K, et al. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Biomaterials 2006; 27: 2035-2041. (Pubitemid 41759497)
7. Ngo TQ, Scherer MA, Zhou FH, Foster BK, Xian CJ,. Expression of bone morphogenic proteins and receptors at the injured growth plate cartilage in young rats. J Histochem Cytochem 2006; 54: 945-954. (Pubitemid 44106872)
8. Laflamme C, Rouabhia M,. Effect of BMP-2 and BMP-7 homodimers and a mixture of BMP-2/BMP-7 homodimers on osteoblast adhesion and growth following culture on a collagen scaffold. Biomed Mater 2008; 3: 1-10.
9. Stephan SJ, Tholpady SS, Gross B, Petrie-Aronin CE, Botchway EA, Park SS, et al. Injectable tissue-engineered bone repair of a rat calvarial defect. Laryngoscope 2010; 120: 895-901.
10. Canter HI, Vargel I, Korkusuz P, Oner F, Gungorduk DB, Erk Y, et al. Effect of use of slow release of bone morphogenetic protein-2 and transforming growth factor-beta-2 in a chitosan gel matrix on cranial bone graft survival in experimental cranial critical size defect model. Annals Plastic Surg 2010; 64: 342-350.
11. Lee JY, Nam SH, Im SY, Park YJ, Lee YM, Lee SJ, et al. Enhanced bone formation by controlled growth factor delivery from chitosan-based biomaterials. J Control Release 2002; 78: 187-197.
12. Dash AK, Cudworth GC,. Therapeutic applications of implantable drug delivery systems. J Pharmacol Toxicol Methods 1998; 40: 1-12. (Pubitemid 29062900)
13. Park H, Park K,. Biocompatibility issues of implantable drug delivery systems. Pharm Res 1996; 13: 1770-1776.
14. Yilgor P, Tuzlakoglu K, Reis RL, Hasirci N, Hasirci V,. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. Biomaterials 2009; 30: 3551-3559.
15. Chen FM, Chen R, Wang XJ, Sun HH, Wu ZF, et al. In vitro cellular responses to scaffolds containing two microencapsulated growth factors. Biomaterials 2009; 30: 5215-5224.
16. Park KH, Kim H, Moon S, Na K,. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. J Biosci Bioeng 2009; 108: 530-537.
17. Niu X, Feng Q, Wang M, Guo X, Zheng Q,. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release. 2009; 134: 111-117.
18. Ruel-Garie'py E, Chenite A, Chaput C, Guirguis S, Leroux JC,. Characterization of thermosensitive chitosan gels for the sustained delivery of drugs. Int J Pharm 2000; 203: 89-98. (Pubitemid 30627629)
19. Sun J, Jiang G, Qiu T, Wang Y, Zhang K, Din F,. Injectable chitosan-based hydrogel for implantable drug delivery: Body response and induced variations of structure and composition. J Biomed Mater Res A 2010; 95: 1019-1027.
20. Chenite A, Chaput C, Wang D, Combes C, Buschmann MD, Hoemann CD, Leroux JC, Atkinson BL, Binette F, Selmani A,. Novel injectable neutral solutions of chitosan form biodegradable gels in situ. Biomaterials 2000; 21: 2155-2161. (Pubitemid 30612386)
21. Nair LS, Starnes T, Ko JK, Laurencin CT,. Development of injectable thermogelling chitosan-inorganic phosphate solutions for biomedical applications. Biomacromolecules 2007; 8: 3779-3785.
22. Ta HT, Han H, Larson I, Dass CR, Dunstan DE,. Chitosan-dibasic orthophosphate hydrogel: A potential drug delivery system. Int J Pharm 2009; 371: 134-141.
23. Bae JW, Go DH, Park KD,. Thermosensitive chitosan as an injectable carrier for local drug delivery. Macromol Res 2006; 14: 461-465. (Pubitemid 44407272)
24. Gutowska A, Jeong B, Jasionowski M,. Injectable gels for tissue engineering. Anatomical Record 2001; 263: 342-349. (Pubitemid 32730261)
25. Hoemann CD, Chenite A, Sun J, Hurtig M, Serreqi A, Buschmann MD, et al. Cytocompatible gel formation of chitosan-glycerol phosphate solutions supplemented with hydroxyl ethyl cellulose is due to the presence of glyoxal. J Biomed Mater Res A 2007; 56: 521-529. (Pubitemid 47557403)
26. Crompton KE, Goud JD, Bellamkond RV, Gengenbach TR, Finkelstein DI, Forsythe JS, et al. Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. Biomaterials 2007; 28: 441-449. (Pubitemid 44740107)
27. Chenite A, Buschmann M, Wang D, Chaput C, Kandani N,. Rheological characterization of thermogelling chitosan/glycerolphosphate solutions. Carbohydr Polym 2001; 46: 39-47. (Pubitemid 32487087)
28. Cho J, Heuzey MC, Begin A, Carreau PJ,. Physical gelation of chitosan in the Presence of β-glycerophosphate: The effect of temperature. Biomacromolecules 2005; 6: 3267-3275. (Pubitemid 41764088)
29. Wu J, Su ZG, Ma GH,. A thermo- and pH-sensitive hydrogel composed of quaternized chitosan/glycerophosphate. Int J Pharm 2006; 315: 1-11. (Pubitemid 43674112)
30. Kim S, Nishimoto SK, Bumgardner JD, Haggard WO, Gaber MW, Yang Y,. A chitosan/β-glycerophosphate thermo-sensitive gel for the delivery of ellagic acid for the treatment of brain cancer. Biomaterials 2010; 31: 4157-4166.
31. Berger J, Reist M, Mayer JM, Felt O, Peppas NA, Gurny R,. Structure and interactions in covalently and ionically crosslinked chitosan hydrogels for biomedical applications. Eur. J Pharm Biopharm 2004; 57: 19-34. (Pubitemid 38058801)
32. Ren D, Yi H, Wang W, Ma X,. The enzymatic degradation and swelling properties of chitosan matrices with different degrees of N-acetylation. Carbohydr Res 2005; 340: 2403-2410. (Pubitemid 41375759)
33. Kim S, Gaber MW, Zawaski JA, Zhang F, Richardson M, Zhang XA, Yang Y,. The inhibition of glioma growth in vitro and in vivo by a chitosan/ellagic acid composite biomaterial. Biomaterials 2009; 30: 4743-4751.
34. Kim S, Liu Y, Gaber MW, Bumgardner JD, Haggard WO, Yang Y,. Development of chitosan-ellagic acid films as a local drug delivery system to induce apoptotic death of human melanoma cells. J Biomed Mater Res B Appl Biomater 2009; 90: 145-155.
35. Bear M, Butcher M, Shaughnessy SG,. Oxidized low-density lipoprotein acts synergistically with b-glycerophosphate to induce osteoblast differentiation in primary cultures of vascular smooth muscle cells. J Cell Biochem 2008; 105: 185-193.
36. Duplomb L, Dagouassat M, Jourdon P, Heymann D,. Differentiation of osteoblasts from mouse embryonic stem cells without generation of embryoid body. In Vitro Cell Dev Biol Animal 2007; 43: 21-24. (Pubitemid 47087334)
37. Nieden N, Kempka G, Ahr HJ,. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation 2003; 71: 18-27. (Pubitemid 38230416)
38. Chung CH, Golub EE, Forbes E, Tokuoka T, Shapiro IM,. Mechanism of action of β-glycerophosphate on bone cell mineralization. Calcif Tissue Int 1992; 51: 305-311.
39. Geiger M, Li RH, Friess W,. Collagen sponges for bone regeneration with rhBMP-2. Adv Drug Deliv Rev 2003; 55: 1613-1629. (Pubitemid 37420006)
40. Dong X, Wang Q, Wu T, Pan H,. Understanding adsorption-desorption dynamics of BMP-2 on hydroxyapatite (001) surface. Biophys J 2007; 93: 750-759. (Pubitemid 47219770)
41. Gunatillake PA, Adhikari R,. Biodegradable synthetic polymers for tissue engineering. Eur Cells Materials 2003; 5: 1-16. (Pubitemid 38957397)
42. Yilgor P, Hasirci N, Hasirci V,. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. J Biomed Mater Res Part A 2009; 93: 528-536.
43. Knippenberg M, Helder MN, Doulabi BZ, Wuisman P, Klein-Nulend J,. Osteogenesis versus chondrogenesis by BMP-2 and BMP-7 in adipose stem cells. Biochem Biophy Res Commun 2006; 342: 902-908. (Pubitemid 43320483)
44. Thies RS, Bauduy M, Ashton BA, Kurtzberg L, Wozney J, Rosen V,. Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W-20-17 stromal cells. Endocrinology 1992; 130: 1318-1324.
45. Kempen D, Lu L, Hefferan TE, Creemers LB, Maran A, Yaszemski MJ, et al. Retention of in vitro and in vivo BMP-2 bioactivity in sustained delivery vehicles for bone tissue engineering. Biomaterials 2008; 29: 3245-3252.
46. Osyczka AM, Diefenderfer DL, Bhargave G, Leboy PS,. Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 2004; 176 (1-3): 109-119. (Pubitemid 38199424)
47. Diefenderfer DL, Osyczka AM, Garino JP, Leboy PS,. Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am A 2003; 85: 19-28. (Pubitemid 36957900)
48. Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RV, Rowe DW, Robey PG,. Bone formation in vivo: Comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation 1997; 63: 1059-1069. (Pubitemid 27190967)
49. Groeneveld EH, Burger HE,. Bone morphogenetic proteins in human bone regeneration. Eur J Endocrinol 2000; 142: 9-21. (Pubitemid 30094193)